1,928 results on '"Gupta L"'
Search Results
2. Occurrence of Elophila Hübner, 1822 and Ephestiopsis Ragonot, 1893 (Lepidoptera: Pyraloidea) larvae under influence of shading on Azolla pinnata R. Br.
3. POS1141 ACTIVE JOINT DISEASE, PAIN AND FATIGUE ALL STRONGLY ASSOCIATE WITH POOR MENTAL HEALTH IN AN INTERNATIONAL COHORT OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVAD SURVEY
4. AB1350 EMINENCE AWARDS IN RHEUMATOLOGY: A GENDER EQUITY ANALYSIS ACROSS INTERNATIONAL SOCIETY DATA
5. AB1636-HPR SOCIAL MEDIA USE BY PHYSIOTHERAPISTS, OCCUPATIONAL THERAPISTS AND ALLIED HEALTHCARE PROFESSIONALS IN KAZAKHSTAN
6. AB1645-PARE DISEASE FLARES IN PATIENTS WITH RHEUMATOID ARTHRITIS FOLLOWING COVID-19 BREAKTHROUGH INFECTION: RESULT FROM COVAD E-SURVEY STUDY
7. Pilocytic astrocytoma of the cerebellopontine angle: a rare case
8. Improvement in dyspareunia after vaginal mesh removal measured by a validated questionnaire
9. Magnetic structures of rare earth intermetallic compounds RCuAs$_2$ (R = Pr, Nd, Tb, Dy, Ho, and Yb)
10. Investigation of Arrott plot and magnetocaloric effect in the complex CaMn7O12 perovskite
11. Coexistence of superconductivity and itinerant ferromagnetism in Sr0.5Ce0.5FBiS2-xSex (x = 0.5 and 1.0), the first non-U material with Tc < TFM
12. Structural and magnetic properties of a new and ordered quaternary alloy MnNiCuSb (SG: F-43m)
13. Upper critical field, critical current density and activation energy of the new La1-xSmxOF0.5BiS2 (x = 0.2, 0.8) superconductor
14. Superconductivity in La1-xSmxO0.5F0.5BiS2 (x = 0.2, 0.8) under hydrostatic pressure
15. Pressure enhanced superconductivity at 10 K in La doped EuBiS2F
16. CuFeAs: A New Member in the 111-Family of Iron-Pnictides
17. Synthesis and properties of SmO0.5F0.5BiS2 and enhancement in Tc in La1-ySmyO0.5F0.5BiS2
18. High spin polarization and the origin of unique ferromagnetic ground state in CuFeSb
19. Stable Length in Inelastic Design Considering Ductility Requirement
20. Si-induced superconductivity and structural transformations in DyRh4B4
21. Seven cases of probable endotoxin poisoning related to contaminated glutathione infusions
22. Effect of Hydrostatic Pressure on Eu3−xSrxBi2S4−ySeyF4 (x = 1 and 2 and y = 1.5 and 2) Superconductors
23. Evaluation of Rotation Capacity of I-shaped Welded Steel Plate Girders
24. Magnetic Transition in the Kondo Lattice System CeRhSn2
25. POS0558 FLARES OF AUTOIMMUNE RHEUMATIC DISEASE FOLLOWING COVID-19 INFECTION: OBSERVATIONS FROM THE COVAD STUDY
26. POS1216 MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: DATA FROM A LARGE, GLOBAL E-SURVEY (COVAD STUDY)
27. AB1295 SAFETY AND TOLERANCE OF ANTI-SARS-CoV-2 VACCINES IN SJÖGREN’S SYNDROME: RESULTS FROM THE COVAD STUDY
28. OP0081 PREVALENCE, CHARACTERISTICS, AND PREDICTORS OF BREAKTHROUGH COVID-19 INFECTIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS: DATA FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY
29. AB0035 CHEMOKINES (IL-8 & GRO-Α) AND CXCR1/2 PATHWAY INDUCES SENESCENCE INDUCTION IN CHONDROCYTES
30. POS1506 IDENTIFYING DETERMINANTS OF FAVOURABLE AND POOR PHYSICAL FUNCTION IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL COLLABORATIVE STUDY
31. POS0573 COMORBIDITIES, COMPLEX MULTIMORBIDITY AND PROMIS HEALTH OUTCOMES AMONGAUTOIMMUNE RHEUMATIC DISEASES: DATA FROM THE COVAD STUDY
32. POS0273 POST COVID-19 SYNDROME IN PATIENTS WITH AUTOIMMUNE RHEUMATIC DISEASES: RESULTS FROM THE COVAD STUDY
33. POS1215 FLARES AFTER COVID-19 INFECTION IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM THE COVAD STUDY
34. AB0591 COVID-19 VACCINE SAFETY DURING PREGNANCY IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
35. POS0549 BREAKTHROUGH SARS-COV-2 INFECTION IN FULLY VACCINATED PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM THE COVID-19 VACCINATION IN AUTOIMMUNE DISEASE (COVAD) STUDY
36. POS1254 REDUCED HEALTH-RELATED QUALITY OF LIFE USING PROMIS IN PATIENTS WITH SYSTEMIC SCLEROSIS: A CROSS-SECTIONAL ANALYSIS FROM THE INTERNATIONAL COVAD-2 E-SURVEY
37. AB0815 CLINICAL PHENOTYPE AND ANTIBODY CORRELATIONS USING IMMUNOPRECIPITATION IN INDIAN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES FROM THE MYOCITE COHORT
38. POS0269 COVID-19 SEVERITY AND VACCINE BREAKTHROUGH INFECTIONS IN SJÖGREN’S SYNDROME: RESULTS FROM THE COVAD STUDY
39. POS1385-HPR ARTIFICIAL INTELLIGENCE APPROACHES FOR RHEUMATOLOGY PRACTICE: RESULTS FROM AN INTERNATIONAL E-SURVEY OF THE DIGITAL RHEUMATOLOGY NETWORK
40. AB0847 COMORBIDITIES IN IDIOPATHIC INFLAMMATORY MYOPATHIES: DATA FROM THE MYOCITE COHORT
41. POS0971 A COMPARISON OF MYOSITIS AUTOANTIBODY AND CLINICAL CHARACTERISTICS AMONG RACIAL GROUPS IN ASIA AND AUSTRALASIA – A COLLABORATIVE MULTICENTRE EFFORT BY THE APLAR MYOSITIS SIG
42. POS1231 IMPAIRED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: A CROSS-SECTIONAL ANALYSIS FROM AN INTERNATIONAL E-SURVEY
43. LB0006 COVID-19 severity, breakthrough infections and anti-SARS-CoV-2 vaccine safety in young people with rheumatic and non-rheumatic autoimmune diseases: results from the COVAD1 and COVAD2 projects
44. POS0880 COMPARATIVE DISEASE BURDEN IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: DATA FROM COVAD PATIENT-REPORTED E-SURVEY
45. AB1312 MYOSITIS PATIENTS WITHOUT AUTOIMMUNE MULTIMORBIDITY AT LOWER RISK OF DELAYED ONSET COVID-19 VACCINE ADVERSE EVENTS THAN OTHER AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY
46. OP0082 COVID-19 VACCINE SAFETY DURING PREGNANCY AND BREASTFEEDING IN WOMEN WITH AUTOIMMUNE DISEASES: RESULTS FROM THE COVAD STUDY
47. Indian Securities Depository System: What Has Gone Wrong?
48. Stable Length in Inelastic Design Considering Ductility Requirement
49. Return on Indian Equities, 1980-99: The Sensex Portfolio
50. Microwave Properties of Borocarbide Superconductors LnNi2B2C (Ln = Y, Er, Tm, Ho)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.